Company name: Cardia Access Inc.
Industry: Medical Device.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Location: Eden Prairie, Minnesota.
Solution/product: Developing lead conductor technology that is patent protected, according to Twin Cities Angel website. Company has no website.
Money raised: $160,000 out of a total of $5.4 million sought.
How it will be used: Unknown; Chairman and CEO John Erb did not immediately respond to a request for comment.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Investors: Twin Cities Angels (only known investor).
Management team: John Erb, chairman and CEO, U.S. Securities and Exchange Commission filing lists Ronald Nelson and Kenneth Cutler as executive officers.
Market size: Total cardiac rhythm management, which includes the lead market, will be $27.7 billion by 2017, according to Global Industry Analysts.
Competitors: Acclarent, Sorin, Medtronic, Boston Scientific and St. Jude Medical.
